
News|Podcasts|April 29, 2025
Insights from a Pharmacy Times Peer Exchange: ADC Drug Design and HER2 Ultra-Low Breast Cancer Indiciations
Author(s)Alexandra Gerlach, Content Producer
Pharmacists discuss how drug design impacts drug efficacy and indications for HER2-low and -ultra-low breast cancer.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Cyclosporiasis Cases Reach 5100: Investigators Zero In On Lettuce, Possible Taco Bell Link
2
Gedatolisib Combination Approved for PIK3CA Wild-Type HR+, HER2– Breast Cancer
3
Subcutaneous Olanzapine in Schizophrenia: Expanding the Utility of a Proven Therapy
4
Rural Health Transformation Efforts Offer an Opportunity for Pharmacy to Shine
5










































































































